Advanced Nucleic Acid Analysis Techniques at TATAA Biocenter

This case study details the advanced nucleic acid analysis techniques employed by TATAA Biocenter, a contract research organization specializing in bioanalysis and biomarker discovery. The document outlines the importance of accurate nucleic acid analysis in the context of developing cell and gene therapies, emphasizing the need for methods such as quantitative PCR (qPCR), digital PCR (dPCR), and next-generation sequencing (NGS). It describes the facility's GLP-accredited laboratory capabilities, including biodistribution studies and transgene expression analysis, which are critical for ensuring the safety and efficacy of therapies involving genetically modified agents. The use of Agilent Fragment Analyzer systems is highlighted, showcasing their role in maintaining high standards of quality control and sample integrity. The case study also discusses the challenges of working with complex sample types and the necessity for robust quality assurance processes. TATAA Biocenter is positioned to lead in the evolving regulatory landscape for gene and cell therapies, contributing to innovation in the pharmaceutical industry.